GPX4 and non-small cell lung carcinoma: Similar results were obtained using Western blotting, which showed that HO-3867 dosage-dependently decreased the protein levels of GPX4 in NSCLC cells, although it had no impact on the protein levels of SLC7A11 (Figure 7(d)).